Many were forced to discontinue therapy or seek alternatives
Gut microbiome studies of both LC (Yeoh et al., 2021) and CFS (Knig et al., 2021) report deficiencies in butyrate and GABA producing bacteria, e.g., Bacteroides (Strandwitz et al., 2018), Bifidobacterium dentium (Pokusaeva et al., 2017), and Lactobacillus brevium (Ko et al., 2013)
Die Auswirkungen einer chronischen Anwendung, potenzielle Arzneimittelwechselwirkungen und die Wirkungen auf spezifische Populationen (Schwangere, Kinder, immungeschwchte Personen) sind weitgehend unbekannt
Active adults Fitness-focused individuals Patients with recovery-focused wellness goals Individuals exploring peptide therapy options Adults interested in mobility support Patients seeking personalized wellness programs Treatment recommendations are individualized and based on provider evaluation, medical history, medications, and wellness goals